Ernexa Therapeutics Inc. Recorded Big Gain
Tue, May 12, 2026 at 07:37 PM
Ernexa Therapeutics Inc. (ERNA:NASDAQ) jumped higher at $12.01, representing a gain of 66.6%. On Tue, May 12, 2026, ERNA:NASDAQ hit a New 2-Week High of $12.01. The stock appeared on our News Catalysts scanner on Mon, May 11, 2026 at 12:11 PM in the 'BIOTECH' category. From Tue, Apr 28, 2026, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Tue, May 12, 2026 at $15.88 with a volume of 19M+.
About Ernexa Therapeutics Inc. (ERNA:NASDAQ)
Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer.
Top 10 Gainers:
- Dreamland Limited (TDIC:NASDAQ), 126.92%
- Broadwind, Inc. (BWEN:NASDAQ), 117.24%
- BuzzFeed, Inc. (BZFD:NASDAQ), 90.44%
- WORK Medical Technology Group LTD (WOK:NASDAQ), 69.9%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 67.13%
- Ernexa Therapeutics Inc. (ERNA:NASDAQ), 66.57%
- Gauzy Ltd. (GAUZ:NASDAQ), 49.34%
- Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 47.55%
- Ambiq Micro Inc. (AMBQ:NYSE), 45.33%
- Eason Technology Limited (DXF:NYSEMKT), 42.27%